Cleared Traditional

V-HYADASE (K222606) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222606 · Vitromed GmbH · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
270d
Days
Class 2
Risk

K222606 is an FDA 510(k) clearance for the V-HYADASE. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Vitromed GmbH (Langenfeld, DE). The FDA issued a Cleared decision on May 26, 2023 after a review of 270 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Vitromed GmbH devices

Submission Details

510(k) Number K222606 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2022
Decision Date May 26, 2023
Days to Decision 270 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
110d slower than avg
Panel avg: 160d · This submission: 270d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 50
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K222606.
V-PVP
K232125 · Vitromed GmbH · Mar 2024
G-Vitri™ Vitrification Freeze Media
K232942 · Gimbo Medical Technology Shenzhen Co., Ltd. · Jan 2024
Dewin Blastocyst Medium (with HSA and without HSA)
K231370 · Donnevie Medical Technology (Shanghai) Co. , Ltd. · Aug 2023
CryoX Vitrification Freeze Kit / Thaw Kit
K223265 · Zhejiang Horizon Medical Technology Co., Ltd. · May 2023
ARTSMedia In Vitro Culture Medium (AM-IVC Medium)
K220715 · Artsmedia Denmark Aps · Feb 2023
V-SPERM WASH
K223117 · Vitromed GmbH · Jan 2023